The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.

NAB, US Bancorp and Alphabet are set to exit payment processing technology provider Poynt in an acquisition sized at up to $365m.

Mayo Clinic had invested in and partnered the medical data software provider before joining a series C round also featuring NTTVC.

Intel will exit the digital loan documentation software publisher in a $279m all-cash acquisition by Wolters Kluwer.

Returning investor Sammons Financial contributed to a round that more than doubled the online life insurer's total funding to $145m.

Novartis Venture Fund is among the participants in a series A round disclosed by the exosite drug developer at its public launch.

Digital card technology provider Ondot Systems had raised more than $50m from investors including Citi Ventures and Intel Capital.

The WuXi AppTec-backed cancer drug developer has now raised $70m in total as it prepares to bring its lead candidate into the clinic.

The Ctrip and Japan Airlines-backed supersonic jet developer pushed its valuation past $1bn in a round led by WRVI Capital.

Capital One Growth Ventures is set to exit the vehicle retail analytics provider in a cash-and-stock acqusition by Vroom.